in a blind crossover study in six subjects with hyperprolactinemia , 0.5 mg mesulergine induced fewer side effects than did 2.5 mg bromocriptine , while the prl release-inhibiting effect of the two was of the same order .
C0020514
hyperprolactinemia
C0006230
bromocriptine